[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific RNA-Based Vaccines Market Report 2017

August 2017 | 111 pages | ID: AEDE6D186AAEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific RNA-Based Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA-Based Vaccines for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific RNA-Based Vaccines market competition by top manufacturers/players, with RNA-Based Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Type I
  • Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of RNA-Based Vaccines for each application, includin
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific RNA-Based Vaccines Market Report 2017

1 RNA-BASED VACCINES OVERVIEW

1.1 Product Overview and Scope of RNA-Based Vaccines
1.2 Classification of RNA-Based Vaccines by Product Category
  1.2.1 Asia-Pacific RNA-Based Vaccines Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific RNA-Based Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.1 Type I
  1.2.2 Type II
1.3 Asia-Pacific RNA-Based Vaccines Market by Application/End Users
  1.3.1 Asia-Pacific RNA-Based Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Asia-Pacific RNA-Based Vaccines Market by Region
  1.4.1 Asia-Pacific RNA-Based Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of RNA-Based Vaccines (2012-2022)
  1.5.1 Asia-Pacific RNA-Based Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC RNA-BASED VACCINES COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific RNA-Based Vaccines Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific RNA-Based Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific RNA-Based Vaccines (Volume and Value) by Type
  2.2.1 Asia-Pacific RNA-Based Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific RNA-Based Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific RNA-Based Vaccines (Volume) by Application
2.4 Asia-Pacific RNA-Based Vaccines (Volume and Value) by Region
  2.4.1 Asia-Pacific RNA-Based Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific RNA-Based Vaccines Revenue and Market Share by Region (2012-2017)

3 CHINA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 China RNA-Based Vaccines Sales and Value (2012-2017)
  3.1.1 China RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 China RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 China RNA-Based Vaccines Sales Price Trend (2012-2017)
3.2 China RNA-Based Vaccines Sales Volume and Market Share by Type
3.3 China RNA-Based Vaccines Sales Volume and Market Share by Application

4 JAPAN RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 Japan RNA-Based Vaccines Sales and Value (2012-2017)
  4.1.1 Japan RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  4.1.3 Japan RNA-Based Vaccines Sales Price Trend (2012-2017)
4.2 Japan RNA-Based Vaccines Sales Volume and Market Share by Type
4.3 Japan RNA-Based Vaccines Sales Volume and Market Share by Application

5 SOUTH KOREA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea RNA-Based Vaccines Sales and Value (2012-2017)
  5.1.1 South Korea RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea RNA-Based Vaccines Sales Price Trend (2012-2017)
5.2 South Korea RNA-Based Vaccines Sales Volume and Market Share by Type
5.3 South Korea RNA-Based Vaccines Sales Volume and Market Share by Application

6 TAIWAN RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan RNA-Based Vaccines Sales and Value (2012-2017)
  6.1.1 Taiwan RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan RNA-Based Vaccines Sales Price Trend (2012-2017)
6.2 Taiwan RNA-Based Vaccines Sales Volume and Market Share by Type
6.3 Taiwan RNA-Based Vaccines Sales Volume and Market Share by Application

7 INDIA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 India RNA-Based Vaccines Sales and Value (2012-2017)
  7.1.1 India RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  7.1.2 India RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 India RNA-Based Vaccines Sales Price Trend (2012-2017)
7.2 India RNA-Based Vaccines Sales Volume and Market Share by Type
7.3 India RNA-Based Vaccines Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia RNA-Based Vaccines Sales and Value (2012-2017)
  8.1.1 Southeast Asia RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia RNA-Based Vaccines Sales Price Trend (2012-2017)
8.2 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Type
8.3 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Application

9 AUSTRALIA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Australia RNA-Based Vaccines Sales and Value (2012-2017)
  9.1.1 Australia RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Australia RNA-Based Vaccines Sales Price Trend (2012-2017)
9.2 Australia RNA-Based Vaccines Sales Volume and Market Share by Type
9.3 Australia RNA-Based Vaccines Sales Volume and Market Share by Application

10 ASIA-PACIFIC RNA-BASED VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 RNA-Based Vaccines Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 RNA-Based Vaccines Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Sanofi-Aventis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 RNA-Based Vaccines Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 RNA-Based Vaccines Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Arrowhead Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 RNA-Based Vaccines Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Benitec Biopharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 RNA-Based Vaccines Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Calimmune Inc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 RNA-Based Vaccines Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Dicerna
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 RNA-Based Vaccines Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Gradalis
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 RNA-Based Vaccines Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Quark
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 RNA-Based Vaccines Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 RXi
10.12 Senesco
10.13 Silence Therapeutics
10.14 Silenseed
10.15 Tekmira
10.16 Alnylam Pharmaceuticals

11 RNA-BASED VACCINES MANUFACTURING COST ANALYSIS

11.1 RNA-Based Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNA-Based Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 RNA-Based Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RNA-BASED VACCINES MARKET FORECAST (2017-2022)

15.1 Asia-Pacific RNA-Based Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific RNA-Based Vaccines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific RNA-Based Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific RNA-Based Vaccines Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific RNA-Based Vaccines Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific RNA-Based Vaccines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific RNA-Based Vaccines Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA-Based Vaccines
Figure Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure Asia-Pacific RNA-Based Vaccines Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of RNA-Based Vaccines by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific RNA-Based Vaccines Market Size (Million USD) by Region (2012-2022)
Figure China RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA-Based Vaccines Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA-Based Vaccines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific RNA-Based Vaccines Sales Share by Players/Suppliers
Figure Asia-Pacific RNA-Based Vaccines Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific RNA-Based Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA-Based Vaccines Revenue Share by Players
Figure 2017 Asia-Pacific RNA-Based Vaccines Revenue Share by Players
Table Asia-Pacific RNA-Based Vaccines Sales and Market Share by Type (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of RNA-Based Vaccines by Type (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Type (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA-Based Vaccines by Region (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Sales Market Share by Region in 2016
Table Asia-Pacific RNA-Based Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Region (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Revenue Market Share by Region in 2016
Table Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific RNA-Based Vaccines Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Sales Market Share by Application (2012-2017)
Figure Asia-Pacific RNA-Based Vaccines Sales Market Share by Application (2012-2017)
Figure China RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure China RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table China RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table China RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table China RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table China RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Japan RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Japan RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure South Korea RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table South Korea RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure South Korea RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table South Korea RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table South Korea RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure South Korea RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Taiwan RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Taiwan RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Taiwan RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Taiwan RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Taiwan RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure India RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table India RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table India RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table India RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table India RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Australia RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Australia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Australia RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Australia RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Australia RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Australia RNA-Based Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Australia RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Australia RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Table Pfizer RNA-Based Vaccines Basic Information List
Table Pfizer RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche RNA-Based Vaccines Basic Information List
Table Roche RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Roche RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi-Aventis RNA-Based Vaccines Basic Information List
Table Sanofi-Aventis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories RNA-Based Vaccines Basic Information List
Table Abbott Laboratories RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Basic Information List
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Benitec Biopharma RNA-Based Vaccines Basic Information List
Table Benitec Biopharma RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Calimmune Inc RNA-Based Vaccines Basic Information List
Table Calimmune Inc RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Dicerna RNA-Based Vaccines Basic Information List
Table Dicerna RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Dicerna RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Gradalis RNA-Based Vaccines Basic Information List
Table Gradalis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Gradalis RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Quark RNA-Based Vaccines Basic Information List
Table Quark RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Quark RNA-Based Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Quark RNA-Based Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table RXi RNA-Based Vaccines Basic Information List
Table Senesco RNA-Based Vaccines Basic Information List
Table Silence Therapeutics RNA-Based Vaccines Basic Information List
Table Silenseed RNA-Based Vaccines Basic Information List
Table Tekmira RNA-Based Vaccines Basic Information List
Table Alnylam Pharmaceuticals RNA-Based Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-Based Vaccines
Figure Manufacturing Process Analysis of RNA-Based Vaccines
Figure RNA-Based Vaccines Industrial Chain Analysis
Table Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2016
Table Major Buyers of RNA-Based Vaccines
Table Distributors/Traders List
Figure Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific RNA-Based Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific RNA-Based Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Revenue Market Share Forecast by Region in 2022
Figure China RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia RNA-Based Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific RNA-Based Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA-Based Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA-Based Vaccines Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific RNA-Based Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific RNA-Based Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories